Literature DB >> 30797734

Fine particulate matter and incidence of metabolic syndrome in non-CVD patients: A nationwide population-based cohort study.

Seulbi Lee1, Hyesook Park2, Soontae Kim3, Eun-Kyung Lee4, Jiyoung Lee5, Young Sun Hong6, Eunhee Ha7.   

Abstract

BACKGROUND: It has been reported that particulate matter (PM) is associated with cardiovascular diseases (CVD) while metabolic syndrome is also an important risk factor for CVD. However, few studies have investigated the epidemiological association between PM and metabolic syndrome.
OBJECTIVE: To investigate the association between one-year exposure to PM with an aerodynamic diameter <2.5 μm (PM2.5) and the risk of metabolic syndrome in Korean adults without CVD.
METHODS: Exposure to PM2.5 was assessed using a Community Multiscale Air Quality (CMAQ) model. Metabolic syndrome was defined by National Cholesterol Education Program Adult Treatment Panel III. Andersen and Gill model with time-varying covariates, considering recurrent events, was used to investigate the association between one-year average PM2.5 and the risk of incident metabolic syndrome in 119,998 adults from the national health screening cohort provided by Korea National Health Insurance from 2009 to 2013.
RESULTS: Higher risk of metabolic syndrome, waist-based obesity, hypertension, hypertriglyceridemia, low HDL cholesterol, and hyperglycemia were significantly associated with a 10-μg/m3 increase in PM2.5 [adjusted hazard ratio (HR): 1.070, 1.510, 1.499, 1.468, 1.627 and 1.380, respectively]. In addition, the risk of metabolic syndrome associated with PM2.5 exposure was significant in the consistently obese group (obese at baseline and endpoint).
CONCLUSION: Exposure to one-year average PM2.5 is associated with an increased risk of metabolic syndrome and its components in adults without CVD. These associations are particularly prominent in the consistently obese group (obese at baseline and endpoint). Our findings indicate that PM2.5 affects the onset of MS and its components which may lead to increase the risk of CVD.
Copyright © 2019 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  Air pollution; Andersen-Gill model; Body mass index; Fine particulate matter; Metabolic syndrome; Recurrent events

Year:  2019        PMID: 30797734     DOI: 10.1016/j.ijheh.2019.01.010

Source DB:  PubMed          Journal:  Int J Hyg Environ Health        ISSN: 1438-4639            Impact factor:   5.840


  12 in total

1.  The Alzheimer's Disease Exposome.

Authors:  Caleb E Finch; Alexander M Kulminski
Journal:  Alzheimers Dement       Date:  2019-09-10       Impact factor: 21.566

Review 2.  Obesity II: Establishing causal links between chemical exposures and obesity.

Authors:  Jerrold J Heindel; Sarah Howard; Keren Agay-Shay; Juan P Arrebola; Karine Audouze; Patrick J Babin; Robert Barouki; Amita Bansal; Etienne Blanc; Matthew C Cave; Saurabh Chatterjee; Nicolas Chevalier; Mahua Choudhury; David Collier; Lisa Connolly; Xavier Coumoul; Gabriella Garruti; Michael Gilbertson; Lori A Hoepner; Alison C Holloway; George Howell; Christopher D Kassotis; Mathew K Kay; Min Ji Kim; Dominique Lagadic-Gossmann; Sophie Langouet; Antoine Legrand; Zhuorui Li; Helene Le Mentec; Lars Lind; P Monica Lind; Robert H Lustig; Corinne Martin-Chouly; Vesna Munic Kos; Normand Podechard; Troy A Roepke; Robert M Sargis; Anne Starling; Craig R Tomlinson; Charbel Touma; Jan Vondracek; Frederick Vom Saal; Bruce Blumberg
Journal:  Biochem Pharmacol       Date:  2022-04-05       Impact factor: 6.100

Review 3.  Particulate matter inhalation and the exacerbation of cardiopulmonary toxicity due to metabolic disease.

Authors:  Lisa Kobos; Jonathan Shannahan
Journal:  Exp Biol Med (Maywood)       Date:  2021-01-19

4.  Long-term impacts of ambient fine particulate matter exposure on overweight or obesity in Chinese adults: The China-PAR project.

Authors:  Sihan Huang; Xinyu Zhang; Zhongying Liu; Fengchao Liang; Jianxin Li; Keyong Huang; Xueli Yang; Jichun Chen; Xiaoqing Liu; Jie Cao; Shufeng Chen; Chong Shen; Ling Yu; Yingxin Zhao; Ying Deng; Dongsheng Hu; Jianfeng Huang; Yang Liu; Xiangfeng Lu; Fangchao Liu; Dongfeng Gu
Journal:  Environ Res       Date:  2021-07-02       Impact factor: 8.431

5.  A Co-Twin control study of fine particulate matter and the prevalence of metabolic syndrome risk factors.

Authors:  Yuhan Zhang; Liuhua Shi; Howard Chang; Joel Schwartz; Qian Di; Jack Goldberg; Viola Vaccarino
Journal:  Environ Res       Date:  2021-06-27       Impact factor: 8.431

6.  Design and Rationale of the Biomarker Center of the Household Air Pollution Intervention Network (HAPIN) Trial.

Authors:  Dana Boyd Barr; Naveen Puttaswamy; Lindsay M Jaacks; Kyle Steenland; Sarah Rajkumar; Savannah Gupton; P Barry Ryan; Kalpana Balakrishnan; Jennifer L Peel; William Checkley; Thomas Clasen; Maggie L Clark
Journal:  Environ Health Perspect       Date:  2020-04-29       Impact factor: 9.031

7.  Long-term ambient PM2.5 exposure associated with cardiovascular risk factors in Chinese less educated population.

Authors:  Jianfeng Lin; Hua Zheng; Peng Xia; Xinqi Cheng; Wei Wu; Yang Li; Chaochao Ma; Guangjin Zhu; Tao Xu; Yali Zheng; Ling Qiu; Limeng Chen
Journal:  BMC Public Health       Date:  2021-12-10       Impact factor: 3.295

Review 8.  Oxidative stress in air pollution research.

Authors:  I S Mudway; F J Kelly; S T Holgate
Journal:  Free Radic Biol Med       Date:  2020-05-01       Impact factor: 8.101

Review 9.  Effects of particulate matter on atherosclerosis: a link via high-density lipoprotein (HDL) functionality?

Authors:  Siri A N Holme; Torben Sigsgaard; Jørn A Holme; Gitte Juel Holst
Journal:  Part Fibre Toxicol       Date:  2020-08-04       Impact factor: 9.400

10.  Association Between Metabolic and Hormonal Derangements and Professional Exposure to Urban Pollution in a High Intensity Traffic Area.

Authors:  Alessio Molfino; Maria Ida Amabile; Maurizio Muscaritoli; Annunziata Germano; Rossella Alfano; Cesarina Ramaccini; Alessandra Spagnoli; Liberato Cavaliere; Gianluca Marseglia; Antonio Nardone; Giuseppina Muto; Umberto Carbone; Maria Triassi; Silvana Fiorito
Journal:  Front Endocrinol (Lausanne)       Date:  2020-08-11       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.